Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
1.630
+0.080 (5.16%)
At close: Nov 28, 2025, 1:00 PM EST
1.660
+0.030 (1.84%)
After-hours: Nov 28, 2025, 4:46 PM EST

Eledon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
122246443163233
Upgrade
Market Cap Growth
-57.46%465.07%38.87%-50.29%-72.98%3004.22%
Upgrade
Enterprise Value
30168-16-34-31119
Upgrade
Last Close Price
1.634.121.802.284.4115.40
Upgrade
PB Ratio
1.072.086.040.370.391.23
Upgrade
P/TBV Ratio
2.092.87-0.610.762.13
Upgrade
Debt / Equity Ratio
0.010.010.050.010.010.00
Upgrade
Quick Ratio
6.5912.1113.128.7119.2846.04
Upgrade
Current Ratio
6.7412.4214.419.1920.0746.57
Upgrade
Return on Equity (ROE)
-95.49%-57.73%-255.03%-70.89%-19.46%-22.80%
Upgrade
Return on Assets (ROA)
-44.22%-33.11%-29.56%-18.88%-12.53%-7.98%
Upgrade
Return on Capital (ROIC)
-64.20%-69.64%-58.09%-19.91%-12.96%-8.28%
Upgrade
Return on Capital Employed (ROCE)
-74.80%-42.60%-50.50%-46.10%-22.20%-6.80%
Upgrade
Earnings Yield
-67.49%-14.70%-267.55%-280.45%-54.69%-9.77%
Upgrade
FCF Yield
-54.89%-19.21%-90.75%-90.62%-45.83%-6.52%
Upgrade
Buyback Yield / Dilution
-94.74%-97.18%-72.34%3.61%-921.03%-121.42%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q